Newsletter
Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more

JAMA Editor’s Summary

Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 05, 2019 issue
November 5, 2019

Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 05, 2019 issue

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp